ATC codes:
L02BA01
Indication
Malignant neoplasms of breast
ICD11 code:
2D2Z
INN
Tamoxifen
Medicine type
Chemical agent
List type
Complementary
Formulations
Oral > Solid:
10 mg (as citrate) ;
20 mg (as citrate)
EML status history
Sex
All
Age
Adolescents and adults
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Read more
about patents.
Summary of evidence and Expert Committee recommendations
In 2015, as part of the comprehensive review of cancer medicines undertaken by the Expert Committee, listing for tamoxifen on the complementary list of the EML for use in treatment protocols for hormone-receptor positive early stage breast cancer was specifically endorsed. The relevant extract from TRS994 regarding the Expert Committee's 2015 consideration of treatment protocols for early stage breast cancer is attached.